Clinical Trials
A Pilot Study to Evaluate the Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal cancer (CRC) Patients with Curative Resections.
Cancer Type
Colon
ClinicalTrials.gov Identifier
NCT02891538
Principal Investigator
Sukeshi Patel Arora MD
For more information about this study
View DetailsAbout This Study
This will be a randomized, controlled pilot trial of patients with histological documentation of primary colon or rectal adenocarcinoma with resectable cancer, who have not received any treatments for cancer. If patient is a candidate for surgical resection, with no planned neoadjuvant chemotherapy, then the patient is eligible. All eligible subjects will be consented prior to surgery.